Compagnie Lombard Odier SCmA’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-1,300
Closed -$146K 622
2020
Q3
$127K Hold
1,300
﹤0.01% 313
2020
Q2
$160K Hold
1,300
0.01% 289
2020
Q1
$114K Hold
1,300
﹤0.01% 287
2019
Q4
$136K Hold
1,300
0.01% 283
2019
Q3
$150K Buy
1,300
+750
+136% +$114K 0.01% 272
2019
Q2
$95K Buy
+550
New +$95.1K ﹤0.01% 311
2017
Q1
Sell
-700
Closed -$78K 865
2016
Q4
$78K Hold
700
﹤0.01% 549
2016
Q3
$93K Hold
700
﹤0.01% 583
2016
Q2
$64K Hold
700
﹤0.01% 631
2016
Q1
$51K Hold
700
﹤0.01% 708
2015
Q4
$49K Hold
700
﹤0.01% 696
2015
Q3
$64K Hold
700
﹤0.01% 581
2015
Q2
$86K Hold
700
﹤0.01% 579
2015
Q1
$64K Buy
+700
New +$56.8K ﹤0.01% 754

Other funds holding GWPH

Compagnie Lombard Odier SCmA's GWPH Position: Q4 2020 in Review

Compagnie Lombard Odier SCmA sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q4 2020, closing a stake of 1,300 shares — an estimated $146K sold.

Compagnie Lombard Odier SCmA first reported a position in GWPH in Q1 2015 and held it in 14 quarters. The position peaked at $160K in Q2 2020. 279 funds tracked by Wall St. Rank hold GWPH as of Q4 2020.

  • Compagnie Lombard Odier SCmA reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q4 2020 after selling out during the quarter.
  • Compagnie Lombard Odier SCmA sold 1,300 GW Pharmaceuticals Plc American Depositary Shares shares in Q4 2020, an estimated $146K.
  • Compagnie Lombard Odier SCmA first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q1 2015 and held it in 14 quarters.
  • Compagnie Lombard Odier SCmA's GW Pharmaceuticals Plc American Depositary Shares position peaked at $160K in Q2 2020.
  • 279 funds tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q4 2020.

Based on Compagnie Lombard Odier SCmA's 13F filing for Q4 2020, filed 9 Feb 2021.